By Dr Heather Valerio

Journal articles

Valerio H; McAuley A; Innes H; Palmateer N; Goldberg DJ; Munro A; Taylor A; Hutchinson SJ, 2018, 'Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era', International Journal of Drug Policy, 52, pp. 115 - 122, http://dx.doi.org/10.1016/j.drugpo.2017.12.014

Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L, 2018, 'Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality – results from two surveys (2016)', HIV Medicine, 19, pp. 11 - 15, http://dx.doi.org/10.1111/hiv.12599

Innes H; McAuley A; Alavi M; Valerio H; Goldberg D; Hutchinson SJ, 2018, 'The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort-study', Hepatology, 67, pp. 97 - 107, http://dx.doi.org/10.1002/hep.29419

Hutchinson S; Valerio H; Dillon J; Fox R; Innes H; Weir A; Barclay S; Mcdonald S; Kennedy N; Fraser A; Stanley A; Bramley P; Hayes P; Goldberg D, 2018, 'GS-017 Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis', Journal of Hepatology, 68, pp. s67, http://dx.doi.org/10.1016/s0168-8278(18)30355-6

McDonald SA; Innes HA; Aspinall E; Hayes PC; Alavi M; Valerio H; Goldberg DJ; Hutchinson SJ, 2017, 'Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era', Journal of Viral Hepatitis, 24, pp. 295 - 303, http://dx.doi.org/10.1111/jvh.12646

Innes H; McDonald S; Hayes P; Dillon JF; Allen S; Goldberg D; Mills PR; Barclay ST; Wilks D; Valerio H; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley A; Bramley P; Hutchinson SJ, 2017, 'Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population', Journal of Hepatology, 66, pp. 19 - 27, http://dx.doi.org/10.1016/j.jhep.2016.08.004

Innes H; Barclay ST; Hayes PC; Fraser A; Dillon JF; Stanley A; Bathgate A; McDonald S; Goldberg D; Valerio H; Fox R; Kennedy N; Bramley P; Hutchinson SJ, 2017, 'PS-035 Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort', Journal of Hepatology, 66, pp. s22 - s23, http://dx.doi.org/10.1016/s0168-8278(17)30306-9

Aspinall EJ; Mitchell W; Schofield J; Cairns A; Lamond S; Bramley P; Peters SE; Valerio H; Tomnay J; Goldberg DJ; Mills PR; Barclay ST; Fraser A; Dillon JF; Martin NK; Hickman M; Hutchinson SJ, 2016, 'A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy', Journal of Viral Hepatitis, 23, pp. 1009 - 1016, http://dx.doi.org/10.1111/jvh.12580

Bulteel N; Partha Sarathy P; Forrest E; Stanley AJ; Innes H; Mills PR; Valerio H; Gunson RN; Aitken C; Morris J; Fox R; Barclay ST, 2016, 'Factors associated with spontaneous clearance of chronic hepatitis C virus infection', Journal of Hepatology, 65, pp. 266 - 272, http://dx.doi.org/10.1016/j.jhep.2016.04.030

Weir A; McLeod A; Innes H; Valerio H; Aspinall EJ; Goldberg DJ; Barclay ST; Dillon JF; Fox R; Fraser A; Hayes PC; Kennedy N; Mills PR; Stanley AJ; Aitken C; Gunson R; Templeton K; Hunt A; McIntyre P; Hutchinson SJ, 2016, 'Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs', Drug and Alcohol Dependence, 165, pp. 53 - 60, http://dx.doi.org/10.1016/j.drugalcdep.2016.05.012

Hutchinson SJ; Dillon JF; Fox R; McDonald SA; Innes HA; Weir A; McLeod A; Aspinall EJ; Palmateer NE; Taylor A; Munro A; Valerio H; Brown G; Goldberg DJ, 2015, 'Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience', International Journal of Drug Policy, 26, pp. 1041 - 1049, http://dx.doi.org/10.1016/j.drugpo.2015.05.019

Valerio H; Goldberg DJ; Lewsey J; Weir A; Allen S; Aspinall EJ; Barclay ST; Bramley P; Dillon JF; Fox R; Fraser A; Hayes PC; Innes H; Kennedy N; Mills PR; Stanley AJ; Hutchinson SJ, 2015, 'Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection', Drug and Alcohol Dependence, 154, pp. 125 - 131, http://dx.doi.org/10.1016/j.drugalcdep.2015.06.032

Innes HA; Mcdonald SA; Dillon JF; Allen S; Hayes PC; Goldberg D; Mills PR; Barclay ST; Wilks D; Valerio H; Fox R; Bhattacharyya D; Kennedy N; Morris J; Fraser A; Stanley AJ; Bramley P; Hutchinson SJ, 2015, 'Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes', Hepatology, 62, pp. 355 - 364, http://dx.doi.org/10.1002/hep.27766

Bulteel N; Partha Sarathy P; Forrest E; Innes H; Mills P; Valerio H; Stanley A; Gunson RN; Aitken C; Morris J; Barclay ST, 2015, 'O062 : Factors associated with spontaneous clearance of chronic hepatitis C virus infection: A retrospective case control study', Journal of Hepatology, 62, pp. S222 - S222, http://dx.doi.org/10.1016/s0168-8278(15)30076-3

Nhean S; Nyborn J; Hinchey D; Valerio H; Kinzel K; Siegel M; Jernigan DH, 2014, 'The frequency of company-sponsored alcohol brand-related sites on facebook™ -2012', Substance Use and Misuse, 49, pp. 779 - 782, http://dx.doi.org/10.3109/10826084.2014.880177

Weir A; Innes H; Mcleod A; Valerio H; Goldberg D; Hutchinson S, 2014, 'O91 EVIDENCE OF REINFECTION WITH HEPATITIS C FOLLOWING SUCCESSFUL TREATMENT WITH ANTIVIRAL THERAPY AMONG PEOPLE WHO INJECT DRUGS IN SCOTLAND', Journal of Hepatology, 60, pp. S37 - S37, http://dx.doi.org/10.1016/s0168-8278(14)60093-3

Valerio HM; Hutchinson SJ; Goldberg DJ; Lewsey J; Weir A; Innes H; Committee OBOTSHCDM, 2014, 'P1292 EVIDENCE OF CONTINUED INJECTING DRUG USE AFTER ATTAINING SUSTAINED TREATMENT-INDUCED CLEARANCE OF THE HEPATITIS C VIRUS: IMPLICATIONS FOR RE-INFECTION', Journal of Hepatology, 60, pp. s520 - s521, http://dx.doi.org/10.1016/s0168-8278(14)61451-3

Diloreto JT; Siegel M; Hinchey D; Valerio H; Kinzel K; Lee S; Chen K; Shoaff JR; Kenney J; Jernigan DH; Dejong W, 2012, 'Assessment of the Average Price and Ethanol Content of Alcoholic Beverages by Brand-United States, 2011', Alcoholism Clinical and Experimental Research, 36, pp. 1288 - 1297, http://dx.doi.org/10.1111/j.1530-0277.2011.01721.x

Conference Papers

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J, 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study', in International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Amin J; Christmass M; Dunlop AJ; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Dore GJ; Treloar C; Grebely J, 2021, 'OPIOID OVERDOSE AND NALOXONE ACCESS AMONG PEOPLE WHO RECENTLY USED OPIOIDS OR RECEIVED OPIOID AGONIST TREATMENT IN AUSTRALIA: THE ETHOS ENGAGE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Alavi M; Valerio H; Law M; Lockart I; Danta M; Grebely J; Amin J; Hajarizadeh B; George J; Dore G, 2022, 'FRI356 Incidence and risk factors of hepatitis C liver morbidity and mortality in the era of direct-acting antiviral therapies: a population-based linkage study', in Journal of Hepatology, Elsevier, Vol. 77, pp. s568 - s569, http://dx.doi.org/10.1016/s0168-8278(22)01458-1

Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Law M; Reid H; Janjua N; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore GJ; Grebely J, 2019, 'HEPATITIS C VIRUS REINFECTION FOLLOWING ANTIVIRAL TREATMENT AMONG PEOPLE WHO USE OR INJECT DRUGS: A SYSTEMATIC REVIEW AND META-ANALYSIS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S50 - S51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

He S; Dore G; Law M; Valerio H; Grebely J; Amin J; Hajarizadeh B; George J; Danta M; Alavi M, 2019, 'Improved survival after hepatitis C-related hepatocellular carcinoma diagnosis in the direct-acting antiviral therapy era in New South Wales, Australia', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Reid H; Law M; Janjua N; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore G; Grebely J, 2019, 'Hepatitis C virus reinfection following antiviral treatment among people who inject drugs: A systematic review, meta-analysis, and meta-regression', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E733 - E733, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Valerio H; Alavi M; Silk D; Treloar C; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Degenhardt L; Dore G; Grebely J, 2019, 'PS-070-Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage study', in Journal of Hepatology, Elsevier, Vol. 70, pp. e42, http://dx.doi.org/10.1016/s0618-8278(19)30076-3

Hutchinson SJ; Valerio H; Dillon JF; Fox R; Innes H; Weir A; Barclay ST; McDonald SA; Kennedy N; Fraser A; Stanley A; Bramley P; Hayes P; Goldberg DJ, 2018, 'Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis', in Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis, presented at EASL

Alavi M; Janjua N; Yu A; Grebely J; Aspinall E; Innes H; Valerio H; Hayes P; Krajden M; Amin J; Law M; George J; Goldberg D; Hutchinson S; Dore G, 2016, 'FRI-417 Does Alcohol Dependency Explain Differences in Rates of Decompensated Cirrhosis among People with a Hepatitis C Notification? An International Comparison', in Journal of Hepatology, Elsevier, Vol. 64, pp. s462 - s463, http://dx.doi.org/10.1016/s0168-8278(16)00776-5

Reports

Alavi M; Valerio H; Selvey C; Dore G, 2019, Hepatitis C Elimination in NSW: Monitoring Evaluation Report 2019, https://kirby.unsw.edu.au/report/hepatitis-c-elimination-nsw-monitoring-and-evaluation-report-2019

Theses / Dissertations

Valerio H, 2021, Elimination of hepatitis C virus among people who inject drugs in Australia

Preprints

Shih ST; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, 2022, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, http://dx.doi.org/10.2139/ssrn.4267510

Shih ST; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, 2022, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, http://dx.doi.org/10.2139/ssrn.4267527

Back to profile page